Related Experiment Video
Updated: Sep 20, 2025

05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.7K
Transfusion Practices in 12 Neonatal Networks: Are We Closer to Adopting a Restrictive Transfusion Approach?
Gil Klinger1,2, Kjell Helenius3, Maximo Vento4
1Department of Neonatal Intensive Care, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Neonatology
|May 28, 2025
Summary
Practices for blood transfusions in preterm infants vary globally. Most neonatal intensive care units (NICUs) now use a restrictive approach, aligning with recent evidence for managing premature babies.
Area of Science:
- Neonatal Medicine
- Pediatric Hematology
- Clinical Practice Guidelines
Background:
- Emerging evidence supports a restrictive approach to blood transfusions for preterm infants.
- This study investigates current transfusion practices in very premature neonates.
Purpose of the Study:
- To survey blood transfusion practices in preterm neonates (<29 weeks' gestation).
- To assess practices across 12 international neonatal networks (iNeo).
Main Methods:
- An online survey was distributed to 608 neonatal intensive care units (NICUs) globally in 2023.
- Practices were surveyed for four distinct clinical scenarios in preterm infants.
- Scenarios included varying levels of respiratory support and postnatal age.
Main Results:
- 382 NICUs (63%) responded, revealing significant variations in transfusion practices.
- A restrictive approach (hematocrit ≤35% or ≤30%) was common for ventilated infants.
- For stable infants, thresholds were often hematocrit ≤30% (noninvasive support) or ≤25% (no support).
Conclusions:
- Substantial variation exists in blood transfusion practices between countries and within networks.
- Over two-thirds of NICUs have adopted a restrictive transfusion approach.
- Further research is required to align practices with intentions and evaluate their impact on outcomes.
Related Concept Videos
Blood Transfusion and Agglutination
11.3K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.3K
Blood Transfusion
821
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
821
Rh Blood Group
1.9K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.9K
Transcytosis of IgG
2.9K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.9K
Bone Marrow Sampling and Transplants
509
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
509

